Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Genotype distribution across metastasis status

From: A germline mutation in the BRCA13’UTR predicts Stage IV breast cancer

All cases M1 M0 p-value OR (95% CI)
TT and GT 17 349 0.040 2.69 (1.05-6.90)
GG 6 331   
Luminal A cases     
TT and GT 11 261 0.029 9.86 (1.26-77.01)
GG 1 234